Each persons immune system and skin sensitivity are unique
There are no injections, no needles, and no fasting windows to manage
Indeed, the combined use of these medications is suggested to be synergistic and, as reported in a recent meta-analysis, superior outcomes with the addition of a GLP-1 RA to SGLT2i can be observed in type 2 diabetes, although observations of cardiovascular and mortality outcomes are limited [29]
Biagi E, Popat U, Raphael R, Eric Y, Giampietro D, Lawrence R, Andreeff M , Brenner M
Mounjaro (tirzepatide): NICE approved tirzepatide for weight management in early 2025 (TA1026), and NHS prescribing through primary care began in June 2025 as part of a phased 12-year rollout
Remember, B12 injections do not cause weight loss